ITGB3 and breast cancer: We showed that blocking VEGFR2 signaling with sunitinib inhibits the ITGB3+ EV–mediated increase in endothelial permeability, suggesting that sunitinib or other VEGF pathway inhibitors might be useful for the prevention or treatment of BC brain metastasis.